Tromp, J M <br/><br/>
Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering.  [electronic resource] 

 -  Oncogene  Sep 2010 
 - 5071-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2010.248  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Biphenyl Compounds--pharmacology<br/>CD40 Antigens--agonists<br/>CD40 Ligand--metabolism<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Drug Resistance, Neoplasm--drug effects<br/>Humans<br/>Immunoglobulin Heavy Chains--genetics<br/>Immunoglobulin Variable Region--genetics<br/>Leukemia, Lymphocytic, Chronic, B-Cell--genetics<br/>Lymphocyte Activation--drug effects<br/>Mice<br/>Mutation--physiology<br/>NF-kappa B--physiology<br/>NIH 3T3 Cells<br/>Nitrophenols--pharmacology<br/>Oligodeoxyribonucleotides--pharmacology<br/>Piperazines--pharmacology<br/>Signal Transduction--drug effects<br/>Sulfonamides--pharmacology<br/>Toll-Like Receptor 9--agonists<br/>bcl-X Protein--metabolism